Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Does Alzheimer’s Disease Accelerate Brain Aging? Updated On: Ene. 20, 2025
Alzheimer's Disease Research Grant

Does Alzheimer’s Disease Accelerate Brain Aging?

Cells & Circuits
a headshot of Dr. Llorens-Martin

Principal Investigator

María Llorens-Martín, PhD

Spanish National Research Council

Madrid, Spain

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$300,000

Active Dates

July 01, 2024 - June 30, 2027

Grant ID

A2024021S

Goals

This project aims to shed light on the pathological mechanisms underlying brain malfunction in people with Alzheimer’s disease.

Summary

The hippocampus, a brain region crucial for learning and memory, generates new neurons throughout life. This process is damaged in people with Alzheimer’s disease, but the cause of these alterations is unknown. Dr. Llorens-Martín and her team will use high-quality human brain samples and cutting-edge genomic and microscopy methodologies to assess the toxicity of the environment that surrounds new neurons. Study findings will identify novel mechanisms responsible for hippocampal perturbation in Alzheimer’s and generate novel resources that allow faster and more accurate diagnosis of this condition.

Unique and Innovative

Our project relies on a unique set of human brain samples collected by our lab over the last 14 years. These samples have been subjected to state-of-the-art tissue preservation and processing methodologies, which ensures the optimal detection of the cellular and molecular mechanisms of interest in this project. Moreover, we will apply a groundbreaking combination of molecular, biochemical, genomic, histological, and microscopy techniques to these human brain samples.

Foreseeable Benefits

The ultimate goal of this project is to develop novel and robust biomarkers for Alzheimer´s disease progression. To this end, the application of cutting-edge genomic techniques will facilitate the identification of groups of genes of particular importance in this disorder. Moreover, we intend to identify particularly vulnerable cell populations, thereby unveiling key novel therapeutic targets for this-yet incurable condition.